Cargando…
Mithramycin A Inhibits Colorectal Cancer Growth by Targeting Cancer Stem Cells
The pivotal role of cancer initiating stem cells (CSCs) in tumor initiation, growth, metastasis and drug resistance has led to the postulation of a ‘total cancer therapy’ paradigm, which involves targeting both cancer cells and CSCs for effective therapy. However, the progress in identifying drugs f...
Autores principales: | Quarni, Waise, Dutta, Rinku, Green, Ryan, Katiri, Sandhyabanu, Patel, Bhaumik, Mohapatra, Shyam S., Mohapatra, Subhra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811578/ https://www.ncbi.nlm.nih.gov/pubmed/31645574 http://dx.doi.org/10.1038/s41598-019-50917-3 |
Ejemplares similares
-
Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
por: Dutta, Rinku, et al.
Publicado: (2021) -
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway
por: Green, Ryan, et al.
Publicado: (2019) -
Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis
por: Howell, Mark C., et al.
Publicado: (2019) -
SARS-CoV-2-Induced Gut Microbiome Dysbiosis: Implications for Colorectal Cancer
por: Howell, Mark C., et al.
Publicado: (2021) -
Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology
por: Dutta, Rinku, et al.
Publicado: (2019)